4.3 Meeting Abstract

Extracellular adherence protein (Eap) of Staphylococcus aureus evades innate immunity by inhibiting complement activation and neutrophil elastase

期刊

IMMUNOBIOLOGY
卷 217, 期 11, 页码 1170-1170

出版社

ELSEVIER GMBH, URBAN & FISCHER VERLAG
DOI: 10.1016/j.imbio.2012.08.118

关键词

-

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Pharmacology & Pharmacy

Compstatins: the dawn of clinical C3-targeted complement inhibition

Christina Lamers, Dimitrios C. Mastellos, Daniel Ricklin, John D. Lambris

Summary: This review discusses the importance of the complement system in the treatment of clinical conditions and the development of treatment methods, focusing on targeted therapy of C3 activation and highlighting the critical role of pegcetacoplan as a C3 inhibitor in treating complement diseases.

TRENDS IN PHARMACOLOGICAL SCIENCES (2022)

Article Oncology

Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis

Sergio Ortiz-Espinosa, Xabier Morales, Yaiza Senent, Diego Alignani, Beatriz Tavira, Irati Macaya, Borja Ruiz, Haritz Moreno, Ana Remirez, Cristina Sainz, Alejandro Rodriguez-Pena, Alvaro Oyarbide, Mikel Ariz, Maria P. Andueza, Karmele Valencia, Alvaro Teijeira, Kai Hoehlig, Axel Vater, Barbara Rolfe, Trent M. Woodruff, Jose Maria Lopez-Picazo, Silvestre Vicent, Grazyna Kochan, David Escors, Ignacio Gil-Bazo, Jose Luis Perez-Gracia, Luis M. Montuenga, John D. Lambris, Carlos Ortiz de Solorzano, Fernando Lecanda, Daniel Ajona, Ruben Pio

Summary: This study reveals that C5a can enhance the capacity of PMN-MDSCs to promote tumor growth and metastasis by inducing the formation of NETs. The formation of NETs is dependent on the production of HMGB1 by cancer cells. Inhibiting C5a, C5aR1, or NETosis can reduce the number of circulating tumor cells and the metastatic burden in a mouse lung metastasis model. The translational relevance of these findings is supported by the stimulation of migration and NETosis in PMN-MDSCs obtained from lung cancer patients.

CANCER LETTERS (2022)

Review Immunology

Application of the C3 inhibitor compstatin in a human whole blood model designed for complement research-20 years of experience and future perspectives

Tom E. Mollnes, Benjamin S. Storm, Ole L. Brekke, Per H. Nilsson, John D. Lambris

Summary: The complement system, initially thought to protect the host from infection, has been shown to have numerous other functions and plays a major role in various diseases. Traditional reductionistic models of complement research are limited, and there is a need for holistic models that retain complement activity and allow for the study of interactions with other inflammatory systems. Two such models using anticoagulated whole blood are described here, which will be useful in further understanding complement-driven diseases.

SEMINARS IN IMMUNOLOGY (2022)

Article Immunology

Bothrops jararaca Snake Venom Inflammation Induced in Human Whole Blood: Role of the Complement System

Thyago Bispo Leonel, Joel Jose Megale Gabrili, Carla Cristina Squaiella-Baptistao, Trent M. Woodruff, John D. Lambris, Denise V. Tambourgi

Summary: This study analyzed the effects of Bothrops jararaca snake venom on the complement system and innate immunity. The venom was found to activate the complement system and induce inflammatory responses. Inhibition of the complement system may represent a potential therapeutic approach for Bothrops jararaca envenoming.

FRONTIERS IN IMMUNOLOGY (2022)

Article Biochemistry & Molecular Biology

Quiescence of Human Monocytes after Affinity Purification: A Novel Method Apt for Monocyte Stimulation Assays

Minh-Thu Nguyen, Leonhard Hubert Schellerhoff, Silke Niemann, Frieder Schaumburg, Mathias Herrmann

Summary: This article introduces an improved protocol for preparing monocytes, which allows the assessment of cytokine release upon external stimulation. By adding a quiescence step, the protocol provides a stable and activatable pure monocyte population.

BIOMOLECULES (2022)

Review Microbiology

Staphylococcus schweitzeri-An Emerging One Health Pathogen?

Chantal Akoua-Koffi, Adele Kacou N'Douba, Joseph Allico Djaman, Mathias Herrmann, Frieder Schaumburg, Silke Niemann

Summary: The Staphylococcus aureus-related complex is composed of multiple species, with S. schweitzeri mainly found in African wildlife and rarely causing infections in humans. However, misidentification may lead to underreporting of S. schweitzeri in humans. Despite the low number of isolates in humans, in vitro assays suggest that S. schweitzeri might be as virulent as S. aureus. Antimicrobial resistance studies show that S. schweitzeri is susceptible to tested antibiotics.

MICROORGANISMS (2022)

Article Engineering, Biomedical

Complement-regulatory biomaterial coatings: Activity and selectivity profile of the factor H-binding peptide 5C6

Clement Bechtler, Sophia Koutsogiannaki, Ekaterina Umnyakova, Amal Hamid, Avneesh Gautam, Yiannis Sarigiannis, Richard B. Pouw, Christina Lamers, Said Rabbani, Christoph Q. Schmidt, John D. Lambris, Daniel Ricklin

Summary: The use of biomaterials in modern medicine has advanced drug delivery strategies and reduced morbidity and mortality. However, immune reactions remain a serious complication.

ACTA BIOMATERIALIA (2023)

Review Hematology

Complement-targeted therapeutics: An emerging field enabled by academic drug discovery

Christina Lamers, Daniel Ricklin, John D. Lambris

Summary: The number of complement inhibitors approved for therapeutic use or in late-stage clinical trials has expanded rapidly in recent years. The sudden emergence of this area in biotech start-ups and pharmaceutical companies is surprising considering the well-established involvement of the complement system in various clinical conditions. However, the complement system has unique characteristics that have delayed its recognition as a traditional drug target, such as concerns about safety and the complexity of its involvement in biological processes.

AMERICAN JOURNAL OF HEMATOLOGY (2023)

Article Cell Biology

Terminal Complement Activation Is Induced by Factors Released from Endplate Tissue of Disc Degeneration Patients and Stimulates Expression of Catabolic Enzymes in Annulus Fibrosus Cells

Amelie Kuhn, Jana Riegger, Graciosa Q. Teixeira, Markus Huber-Lang, John D. Lambris, Cornelia Neidlinger-Wilke, Rolf E. Brenner

Summary: Terminal complement complex deposition was found in human degenerated discs. The study investigated the mechanisms and effects of terminal complement activation in annulus fibrosus (AF) cells. Complement inhibitors effectively suppressed anaphylatoxin generation and TCC deposition induced by zymosan. Gene expression of ADAMTS4, MMP1, and COX2 was influenced by C3 and C5 blockade. Degenerated endplate tissue secreted soluble factors that enhanced direct C5 cleavage. These findings suggest the functional involvement of terminal complement activation in disc degeneration and the role of degenerated tissue in complement activation.
Article Infectious Diseases

Discrimination between hypervirulent and non-hypervirulent ribotypes of Clostridioides difficile by MALDI-TOF mass spectrometry and machine learning

Ahmed Mohamed Mostafa Abdrabou, Issa Sy, Markus Bischoff, Manuel J. Arroyo, Soeren L. Becker, Alexander Mellmann, Lutz von Mueller, Barbara Gaertner, Fabian K. Berger

Summary: This study evaluated the feasibility of using MALDI-TOF technology combined with machine learning models to distinguish between hypervirulent and non-hypervirulent strains of Clostridioides difficile. The results showed that certain machine learning models could accurately differentiate between hypervirulent and non-hypervirulent strains with a high accuracy rate and further sub-cluster the hypervirulent strains into three subgroups. The conclusion is that MALDI-TOF combined with machine learning is a reliable tool for rapid identification of major European hypervirulent strains.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2023)

Article Chemistry, Analytical

Simultaneous quantification of atorvastatin, erlotinib and OSI-420 in rat serum and liver microsomes using a novel liquid chromatography-mass spectrometry method

Marta A. Rysz, Jonny Kinzi, Anima M. Schafer, Katja In-Albon, Simone Zurcher, Seraina Schmidlin, Isabell Seibert, Oliver Schwardt, Daniel Ricklin, Henriette E. Meyer zu Schwabedissen

Summary: In this study, a bioanalytical method for simultaneous determination of atorvastatin, erlotinib, and its metabolite OSI-420 in biological samples was developed and validated. The results showed that female rats exhibited slower metabolism of erlotinib compared to male rats, and the presence of atorvastatin inhibited the metabolism of erlotinib. Non-compartmental pharmacokinetic analysis revealed a lower clearance of erlotinib when co-administered with atorvastatin.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2023)

Article Microbiology

The secreted tyrosine phosphatase PtpA promotes Staphylococcus aureus survival in RAW 264.7 macrophages through decrease of the SUMOylation host response

Nadhuma Youssouf, Marianne Martin, Markus Bischoff, Philippe Soubeyran, Laila Gannoun-Zaki, Virginie Molle

Summary: Staphylococcus aureus inhibits the host SUMOylation response to enhance its survival and persistence within the host.

MICROBIOLOGY SPECTRUM (2023)

Article Hematology

Exploring the function of factor XIII free B subunit: Interactions with complement factors and a novel approach to identify potential binding partners

Bojun Li, Clement Bechtler, Lorenz Jenny, Daniel Ricklin, Verena Schroeder

Summary: This study reveals that free FXIII-B has no direct role in regulating the complement system, despite its structural similarity to major complement regulators. Alpha 2MG is identified as a potential binding partner for free FXIII-B, although its direct interactions and functional effects remain to be validated.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2022)

Meeting Abstract Biochemistry & Molecular Biology

Optimization of factor H-binding peptides for the protection of biosurfaces

Ekaterina Umnyakova, Clement Bechtler, Richard Pouw, John Lambris, Daniel Ricklin

MOLECULAR IMMUNOLOGY (2022)

暂无数据